Hillary Clinton called on pharmaceutical company Mylan NV (MYL) to voluntarily drop the price of their severe allergy treatment drug EpiPen, which has increased in price by 400% in the past decade."That's outrageous - and it's just the latest troubling example of a company taking advantage of its consumers," Clinton said in a statement. "It's wrong when drug companies put profits ahead of patients, raising prices without justifying the value behind them."The stock closed down 5.46% @ $43.13Welcome to the election season. Beware of politicians. I will stay out of pharma stocks for the nearest couple of months.